Literature DB >> 25125047

Does early verbal fluency decline after STN implantation predict long-term cognitive outcome after STN-DBS in Parkinson's disease?

Alaina Borden1, David Wallon2, Romain Lefaucheur1, Stéphane Derrey3, Damien Fetter1, Marc Verin4, David Maltête5.   

Abstract

BACKGROUNDS: An early and transient verbal fluency (VF) decline and impairment in frontal executive function, suggesting a cognitive microlesion effect may influence the cognitive repercussions related to subthalamic nucleus deep brain stimulation (STN-DBS).
METHODS: Neuropsychological tests including semantic and phonemic verbal fluency were administered both before surgery (baseline), the third day after surgery (T3), at six months (T180), and at an endpoint multiple years after surgery (Tyears).
RESULTS: Twenty-four patients (mean age, 63.5 ± 9.5 years; mean disease duration, 12 ± 5.8 years) were included. Both semantic and phonemic VF decreased significantly in the acute post-operative period (44.4 ± 28.2% and 34.3 ± 33.4%, respectively) and remained low at 6 months compared to pre-operative levels (decrease of 3.4 ± 47.8% and 10.8 ± 32.1%) (P < 0.05). Regression analysis showed phonemic VF to be an independent factor of decreased phonemic VF at six months. Age was the only independent predictive factor for incident Parkinson's disease dementia (PDD) (F (4,19)=3.4, P<0.03).
CONCLUSION: An acute post-operative decline in phonemic VF can be predictive of a long-term phonemic VF deficit. The severity of this cognitive lesion effect does not predict the development of dementia which appears to be disease-related.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Deep brain stimulation; Dementia; Microlesion; Parkinson's disease; Subthalamic nucleus; Verbal fluency

Mesh:

Year:  2014        PMID: 25125047     DOI: 10.1016/j.jns.2014.07.063

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

1.  Evidence of improved immediate verbal memory and diminished category fluency following STN-DBS in Chinese-Cantonese patients with idiopathic Parkinson's disease.

Authors:  Venus Tang; Cannon X L Zhu; Danny Chan; Claire Lau; Anne Chan; Vincent Mok; Jonas Yeung; Wai Sang Poon
Journal:  Neurol Sci       Date:  2015-02-24       Impact factor: 3.307

Review 2.  The Subthalamic Nucleus, Limbic Function, and Impulse Control.

Authors:  P Justin Rossi; Aysegul Gunduz; Michael S Okun
Journal:  Neuropsychol Rev       Date:  2015-11-14       Impact factor: 7.444

3.  Neuropsychological predictors of patient-reported cognitive decline after deep brain stimulation in Parkinson's disease.

Authors:  Kelly A Mills; Kristyn Donohue; Aathman Swaminathan; Jeannie-Marie Leoutsakos; Gwenn Smith; Jason Brandt
Journal:  J Clin Exp Neuropsychol       Date:  2018-10-08       Impact factor: 2.475

4.  Deep Brain Stimulation Frequency of the Subthalamic Nucleus Affects Phonemic and Action Fluency in Parkinson's Disease.

Authors:  Valéria de Carvalho Fagundes; Carlos R M Rieder; Aline Nunes da Cruz; Bárbara Costa Beber; Mirna Wetters Portuguez
Journal:  Parkinsons Dis       Date:  2016-12-05

5.  Subthalamic Nucleus Stimulation Does Not Have Any Acute Effects on Verbal Fluency or on Speed of Word Generation in Parkinson's Disease.

Authors:  Cyril Atkinson-Clement; Friederike Leimbach; Marjan Jahanshahi
Journal:  Parkinsons Dis       Date:  2019-10-03

6.  Altered Interhemispheric Functional Connectivity Associated With Early Verbal Fluency Decline After Deep Brain Stimulation in Parkinson's Disease.

Authors:  Bei Luo; Wenwen Dong; Lei Chang; Chang Qiu; Yue Lu; Dongming Liu; Chen Xue; Li Zhang; Weiguo Liu; Wenbin Zhang; Jun Yan
Journal:  Front Aging Neurosci       Date:  2022-04-01       Impact factor: 5.702

Review 7.  Some Clinically Useful Information that Neuropsychology Provides Patients, Carepartners, Neurologists, and Neurosurgeons About Deep Brain Stimulation for Parkinson's Disease.

Authors:  Alexander I Tröster
Journal:  Arch Clin Neuropsychol       Date:  2017-11-01       Impact factor: 2.813

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.